{"id":65689,"date":"2021-07-21T22:39:00","date_gmt":"2021-07-21T22:39:00","guid":{"rendered":""},"modified":"2021-07-21T22:39:00","modified_gmt":"2021-07-21T22:39:00","slug":"el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta","status":"publish","type":"post","link":"https:\/\/primereando.com.ar\/index.php\/2021\/07\/21\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\/65689\/","title":{"rendered":"El 95% de los vacunados con Sinopharm desarrollan anticuerpos contra la variante Delta"},"content":{"rendered":"<p>El 95% de las personas que recibieron las dos dosis de la vacuna de Sinopharm contra el coronavirus desarrollaron anticuerpos frente a la variante Delta, similares a los que se desarrollan despu&eacute;s de una infecci&oacute;n natural.<\/p>\n<p>La investigaci&oacute;n arroj&oacute; que las personas de 20 a 39 a&ntilde;os presentaron tasas de seroconversi&oacute;n (t&iacute;tulos de anticuerpos) muy elevadas (98,9%), en individuos mayores de 60 a&ntilde;os (93,3%) fueron menores.<\/p>\n<p>Adem&aacute;s, la vacuna indujo anticuerpos neutralizantes en el 81,25% de los receptores de la vacuna y estos niveles de anticuerpos neutralizantes fueron similares a los niveles observados despu&eacute;s de una infecci&oacute;n natural.<\/p>\n<p>El trabajo fue difundido por los investigadores de la Universidad de Sri Jayewardenepura que realizaron el estudio junto al Consejo Municipal de Colombo en Sri Lanka y la Universidad de Oxford.<\/p>\n<p>Seg&uacute;n se&ntilde;al&oacute; el comunicado de la universidad, los niveles de anticuerpos contra Delta y Beta (detectada por primera vez en Sud&aacute;frica) &quot;fueron similares a los niveles posteriores a la infecci&oacute;n natural, aunque los niveles de anticuerpos fueron m&aacute;s bajos para el Alfa (detectada por primera vez en Reino Unido)&quot;.<\/p>\n<p>La vacuna tambi&eacute;n indujo respuestas de c&eacute;lulas T y c&eacute;lulas B de memoria. &quot;Los receptores de la vacuna solo tuvieron una reducci&oacute;n de 1,38 veces en los t&iacute;tulos de anticuerpos a Delta en comparaci&oacute;n con la variante de Wuhan, en comparaci&oacute;n con una reducci&oacute;n de 10 veces a Beta&quot;, a&ntilde;ade el informe.&nbsp;<\/p>\n<p>Sinopharm, aprobada por la OMS, present&oacute; meses atr&aacute;s estudios en varios pa&iacute;ses con una eficacia general de casi 80%. La f&oacute;rmula es usada en decenas de pa&iacute;ses con compras directas o con entregas a trav&eacute;s del mecanismo COVAX.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La investigaci\u00f3n realizada en pacientes de India indic\u00f3 que las dosis crean defensas en niveles similares a las personas que sufrieron un contagio de coronavirus.<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[525,718],"class_list":["post-65689","post","type-post","status-publish","format-standard","hentry","category-actualidad","tag-delta","tag-sinopharm"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>El 95% de los vacunados con Sinopharm desarrollan anticuerpos contra la variante Delta - Primereando<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/primereando.com.ar\/index.php\/2021\/07\/21\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\/65689\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"El 95% de los vacunados con Sinopharm desarrollan anticuerpos contra la variante Delta - Primereando\" \/>\n<meta property=\"og:description\" content=\"La investigaci\u00f3n realizada en pacientes de India indic\u00f3 que las dosis crean defensas en niveles similares a las personas que sufrieron un contagio de coronavirus.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/primereando.com.ar\/index.php\/2021\/07\/21\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\/65689\/\" \/>\n<meta property=\"og:site_name\" content=\"Primereando\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-21T22:39:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/primereando.com.ar\/wp-content\/uploads\/5ffb405034a73a034b790dd3\/720.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/primereando.com.ar\\\/index.php\\\/2021\\\/07\\\/21\\\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\\\/65689\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/primereando.com.ar\\\/index.php\\\/2021\\\/07\\\/21\\\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\\\/65689\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"El 95% de los vacunados con Sinopharm desarrollan anticuerpos contra la variante Delta\",\"datePublished\":\"2021-07-21T22:39:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/primereando.com.ar\\\/index.php\\\/2021\\\/07\\\/21\\\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\\\/65689\\\/\"},\"wordCount\":336,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/primereando.com.ar\\\/#organization\"},\"keywords\":[\"Delta\",\"Sinopharm\"],\"articleSection\":[\"Actualidad\"],\"inLanguage\":\"es-AR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/primereando.com.ar\\\/index.php\\\/2021\\\/07\\\/21\\\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\\\/65689\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/primereando.com.ar\\\/index.php\\\/2021\\\/07\\\/21\\\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\\\/65689\\\/\",\"url\":\"https:\\\/\\\/primereando.com.ar\\\/index.php\\\/2021\\\/07\\\/21\\\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\\\/65689\\\/\",\"name\":\"El 95% de los vacunados con Sinopharm desarrollan anticuerpos contra la variante Delta - Primereando\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/primereando.com.ar\\\/#website\"},\"datePublished\":\"2021-07-21T22:39:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/primereando.com.ar\\\/index.php\\\/2021\\\/07\\\/21\\\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\\\/65689\\\/#breadcrumb\"},\"inLanguage\":\"es-AR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/primereando.com.ar\\\/index.php\\\/2021\\\/07\\\/21\\\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\\\/65689\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/primereando.com.ar\\\/index.php\\\/2021\\\/07\\\/21\\\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\\\/65689\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/primereando.com.ar\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"El 95% de los vacunados con Sinopharm desarrollan anticuerpos contra la variante Delta\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/primereando.com.ar\\\/#website\",\"url\":\"https:\\\/\\\/primereando.com.ar\\\/\",\"name\":\"Primereando\",\"description\":\"Portal de noticias de la Provincia de Buenos Aires\",\"publisher\":{\"@id\":\"https:\\\/\\\/primereando.com.ar\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/primereando.com.ar\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es-AR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/primereando.com.ar\\\/#organization\",\"name\":\"Primereando\",\"url\":\"https:\\\/\\\/primereando.com.ar\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-AR\",\"@id\":\"https:\\\/\\\/primereando.com.ar\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/primereando.com.ar\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/primereando-logo.png\",\"contentUrl\":\"https:\\\/\\\/primereando.com.ar\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/primereando-logo.png\",\"width\":360,\"height\":96,\"caption\":\"Primereando\"},\"image\":{\"@id\":\"https:\\\/\\\/primereando.com.ar\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"El 95% de los vacunados con Sinopharm desarrollan anticuerpos contra la variante Delta - Primereando","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/primereando.com.ar\/index.php\/2021\/07\/21\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\/65689\/","og_locale":"es_ES","og_type":"article","og_title":"El 95% de los vacunados con Sinopharm desarrollan anticuerpos contra la variante Delta - Primereando","og_description":"La investigaci\u00f3n realizada en pacientes de India indic\u00f3 que las dosis crean defensas en niveles similares a las personas que sufrieron un contagio de coronavirus.","og_url":"https:\/\/primereando.com.ar\/index.php\/2021\/07\/21\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\/65689\/","og_site_name":"Primereando","article_published_time":"2021-07-21T22:39:00+00:00","og_image":[{"url":"https:\/\/primereando.com.ar\/wp-content\/uploads\/5ffb405034a73a034b790dd3\/720.jpeg","width":1,"height":1,"type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/primereando.com.ar\/index.php\/2021\/07\/21\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\/65689\/#article","isPartOf":{"@id":"https:\/\/primereando.com.ar\/index.php\/2021\/07\/21\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\/65689\/"},"author":{"name":"","@id":""},"headline":"El 95% de los vacunados con Sinopharm desarrollan anticuerpos contra la variante Delta","datePublished":"2021-07-21T22:39:00+00:00","mainEntityOfPage":{"@id":"https:\/\/primereando.com.ar\/index.php\/2021\/07\/21\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\/65689\/"},"wordCount":336,"commentCount":0,"publisher":{"@id":"https:\/\/primereando.com.ar\/#organization"},"keywords":["Delta","Sinopharm"],"articleSection":["Actualidad"],"inLanguage":"es-AR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/primereando.com.ar\/index.php\/2021\/07\/21\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\/65689\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/primereando.com.ar\/index.php\/2021\/07\/21\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\/65689\/","url":"https:\/\/primereando.com.ar\/index.php\/2021\/07\/21\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\/65689\/","name":"El 95% de los vacunados con Sinopharm desarrollan anticuerpos contra la variante Delta - Primereando","isPartOf":{"@id":"https:\/\/primereando.com.ar\/#website"},"datePublished":"2021-07-21T22:39:00+00:00","breadcrumb":{"@id":"https:\/\/primereando.com.ar\/index.php\/2021\/07\/21\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\/65689\/#breadcrumb"},"inLanguage":"es-AR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/primereando.com.ar\/index.php\/2021\/07\/21\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\/65689\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/primereando.com.ar\/index.php\/2021\/07\/21\/el-95-de-los-vacunados-con-sinopharm-desarrollan-anticuerpos-contra-la-variante-delta\/65689\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/primereando.com.ar\/"},{"@type":"ListItem","position":2,"name":"El 95% de los vacunados con Sinopharm desarrollan anticuerpos contra la variante Delta"}]},{"@type":"WebSite","@id":"https:\/\/primereando.com.ar\/#website","url":"https:\/\/primereando.com.ar\/","name":"Primereando","description":"Portal de noticias de la Provincia de Buenos Aires","publisher":{"@id":"https:\/\/primereando.com.ar\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/primereando.com.ar\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es-AR"},{"@type":"Organization","@id":"https:\/\/primereando.com.ar\/#organization","name":"Primereando","url":"https:\/\/primereando.com.ar\/","logo":{"@type":"ImageObject","inLanguage":"es-AR","@id":"https:\/\/primereando.com.ar\/#\/schema\/logo\/image\/","url":"https:\/\/primereando.com.ar\/wp-content\/uploads\/2021\/12\/primereando-logo.png","contentUrl":"https:\/\/primereando.com.ar\/wp-content\/uploads\/2021\/12\/primereando-logo.png","width":360,"height":96,"caption":"Primereando"},"image":{"@id":"https:\/\/primereando.com.ar\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/primereando.com.ar\/index.php\/wp-json\/wp\/v2\/posts\/65689","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/primereando.com.ar\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/primereando.com.ar\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/primereando.com.ar\/index.php\/wp-json\/wp\/v2\/comments?post=65689"}],"version-history":[{"count":0,"href":"https:\/\/primereando.com.ar\/index.php\/wp-json\/wp\/v2\/posts\/65689\/revisions"}],"wp:attachment":[{"href":"https:\/\/primereando.com.ar\/index.php\/wp-json\/wp\/v2\/media?parent=65689"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/primereando.com.ar\/index.php\/wp-json\/wp\/v2\/categories?post=65689"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/primereando.com.ar\/index.php\/wp-json\/wp\/v2\/tags?post=65689"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}